RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Lundbeckfonden Emerge
L

Lundbeckfonden Emerge portfolio

Lundbeckfonden Emerge has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $80M.
Latest deal: NMD Pharma · Nov 15, 2023.
About this page

Its most recent investment on record is NMD Pharma's $80M Series B+ round in November 2023, alongside Novo Holdings, Inkef, Jeito Capital and 1 other. That company is in Health and bio. It has co-invested with Inkef, Novo Holdings and Roche Venture Fund, most often Inkef (2 rounds).

What Lundbeckfonden Emerge invests in

How Lundbeckfonden Emerge invests

StageDealsCapital in rounds
Series B+ 1 50%$80M
Series A 1 50%undisclosed
YearDealsCapital in rounds
2018 1 50%undisclosed
2023 1 50%$80M

Lundbeckfonden Emerge portfolio companies

CompanyRound with Lundbeckfonden EmergeTotal raisedLatest raise
NNMD Pharma
Health and bio
Series B+ · $80M$80MNov 15, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Lundbeckfonden Emerge. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Lundbeckfonden Emerge, which is a subset of its real portfolio. API: /api/v1/investors/lundbeckfonden-emerge (get a free API key). More: the most active VC firms and new venture capital funds.